血清CEA、CA125、AFP与慢性乙型肝炎病情的相关性

doi:10.3969/j.issn.1001-8131.2024.03.009

摘要
图/表
参考文献
相关文章 (10)

全文: PDF (390 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨癌胚抗原（Serum carcinoembryonic antigen,CEA）、糖类抗原125（Carbohydrate antigen 125,CA125）、甲胎蛋白（Alpha Feto Protein,AFP）与慢性乙型肝炎（Chronic hepatitis B,CHB）病情的相关性。方法选取CHB患者78例,结合其病情严重程度分为轻度组（n=26）、中度组（n=26）及重度组（n=26）,另选取同期健康体检者26例为对照组。所有人员均进行血清CEA、CA125、AFP水平检测,记录患者肝肾功能并分析终末期肝病模型（Model for End-stage Liver Disease,MELD）评分。分析血清CEA、CA125、AFP的阳性检出率,并对比各组之间的血清CEA、CA125、AFP水平及MELD评分,分析相关性。结果重度组血清CEA阳性检出率3.85%（1/26）、CA125阳性检出率7.69%（2/26）与中度组3.85%（1/26）、7.69%（2/26）、轻度组3.85%（1/26）、3.85%（1/26）比较差异无统计学意义（P>0.05）;重度组AFP阳性检出率50.00%（13/26）较中度组26.92%（7/26）、轻度组19.23%（5/26）高（P<0.05）;重度组、中度组、轻度组、对照组血清CEA、CA125水平对比差异无统计学意义（P>0.05）;与对照组相比,重度组、中度组、轻度组AFP水平、MELD评分较高（P<0.05）;Pearson分析显示,血清AFP水平（r=0.658,r=0.671）与慢性乙型肝炎患者MELD评分、病情程度呈正相关（P<0.05）。结论血清AFP水平会随着CHB患者病情加重而逐渐提高,且AFP水平与CHB的病情程度呈正相关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	侯亚
	骆焕

关键词 ：慢性乙型肝炎, 血清癌胚抗原, 糖类抗原125, 甲胎蛋白

Abstract：Objective To investigate the correlation between serum carcinoembryonic antigen（CEA）,carbohydrate antigen 125（CA125）,and alpha fetoprotein（AFP）and the illnesscondition of chronic hepatitis B（CHB）. Methods 78 cases of patients with CHB in our hospital were selected,and they were divided into a mild group（n=26）,a moderate group（n=26）,and a severe group（n=26）based on the severity degree of the irillness condition.In addition,26 healthy individuals in the same period were selected as the control group.All personnel were tested for serum CEA,CA125,and AFP levels,the patients' liver and kidney functions were recorded,and the scores of Model for End Stage Liver Disease（MELD）were analyzed.The positive detection rates of serum CEA,CA125,and AFP were analyzed,and the levels of serum CEA,CA125,AFP,and as well as MELD scores among the groups were compared to analyze the correlation. Results There were no significant differences in the detectable rate of CEA positive 3.85%（1/26）and detectable rate of CA125positive7.69%（2/26）in the severe group compared with 3.85%（1/26）and 7.69%（2/26）in the moderate group and 3.85%（1/26）and 3.85%（1/26）in the mild group（P>0.05）.The detectable rate of AFP positivein severe group was 50.00%（13/26）,which was higher than 26.92%（7/26）in the moderate group and 19.23%（5/26）in the mild group（P<0.05）;There were no significant differences in serum CEA and CA125 levels among the severegroup,the moderategroup,the mildgroup,and the control group（P>0.05）;Compared with the control group,the AFP levels and MELD scores in the severegroup,the moderategroup,and the mild group were higher（P<0.05）;Pearson analysis showed that serum AFP level（r=0.658,r=0.671）was positively correlated with MELD scores and severity degree of illnessconditionof chronic hepatitis B（P<0.05）. Conclusion The serum AFP level will gradually increase with the aggravation of CHB patients,and there is a positive correlation between the AFP level and the severity of illnesscondition of CHB.

Key words： Chronic hepatitis B Serum carcinoembryonic antigen Carbohydrate antigen 125 Alpha fetoprotein

收稿日期: 2023-07-20

PACS:

R575.2

引用本文:

侯亚, 骆焕. 血清CEA、CA125、AFP与慢性乙型肝炎病情的相关性[J]. 哈尔滨医药, 2024, 44(3): 26-28.
Hou Ya, Luo Huan. Correlation between Serum CEA,CA125 and AFP the Illnesscondition of Chronic Hepatitis B. journal1, 2024, 44(3): 26-28.

链接本文:

http://www.hrbyybjb.org.cn/CN/10.3969/j.issn.1001-8131.2024.03.009 或 http://www.hrbyybjb.org.cn/CN/Y2024/V44/I3/26

[1] 秦旭,侯志云,张松,等.血清M2BPGi、MFAP4水平与慢性乙型肝炎病情进展的相关性[J].中西医结合肝病杂志,2021,31(12):1126-1129.
[2] 郭丽. 慢性乙型肝炎和肝硬化患者AFP、CA125、CA199和CEA检测分析[J].罕少疾病杂志,2018,25(1):66-68.
[3] Na Yang,Jin Feng,Taicheng Zhou,et al.Relationship between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients[J].J Med Virol,2018,90(7):1240-1245.
[4] 吴丹,张锡坚,陈伟.乙肝肝硬化患者血清HBV-DNA水平与肝功能、CEA及AFP水平的相关性[J].海南医学,2022,33(21):2815-2817.
[5] 翁洋,王吉魁,温艳惠,等.血清AFP、CEA、CA19-9和CA125检测在原发性和转移性肝细胞癌诊断中的临床价值[J].中国医科大学学报,2016,45(5):470-472.
[6] 周海丰. 慢性乙型肝炎、乙肝肝硬化及原发性肝癌患者血清CEA、AFP、CA125和CA199水平检测分析[J].临床合理用药杂志,2020,13(23):124-126.
[7] 中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版)[J].中华传染病杂志,2019,37(12):711-736.
[8] Meng Lan Wang,Juan Liao,Feng Ye,et al.Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis B patients[J].J Med Virol,2021,93(6):3688-3696.
[9] 马恺,黄宁,周川平.血清CA125水平与慢性乙型肝炎合并肝硬化患者发生肝纤维化相关性分析[J].贵州医药,2020,44(10):1630-1631.
[10] 宣碧碧,徐永红,杜忠彩,等.慢性乙型肝炎和乙型肝炎肝硬化患者发生低病毒血症的影响因素及其与肝脏炎症、肝纤维化进展的关系[J].临床肝胆病杂志,2022,38(10):2252-2259.
[11] 黎增辉. 血清AFP-L3%、CA125、CA199和IL-6变化与乙肝后肝硬化和癌变的相关性研究[J].临床输血与检验,2019,21(5):535-539.
[12] 吴婷,祝源,肖大平,等.血清CEA、CA125、AFP水平变化与慢性乙型肝炎患者病情的相关性分析[J].检验医学与临床,2020,17(23):3494-3496.
[13] 朱壹澎,卢高峰,黄丽娜,等.血清CA125、CA199、CEA、AFP检测在肝炎与肝硬化鉴别诊断中的价值[J].山东医药,2019,59(1):46-48.
[14] 崔怀中,王莹,徐爱芳,等.血清甲胎蛋白及其L3异质体联合检测在慢性乙型肝炎相关性肝癌诊断中的价值研究[J].中国卫生检验杂志,2021,31(24):2998-3000.
[15] 王名南,吴少麟,廖燕飞,等.血清CEA、CA125、CA199及AFP联合检测在诊断不同肝病的临床应用价值[J].中国医学创新,2018,15(19):135-138.